Jobelyn on Trial at Dana Faber Cancer Center An American, whose wife is an associate professor in the department of occupational therapy, Boston University, Massachusetts, USA. He had Acute Myeloid Leukemia, refractory type M-O. He received three courses of chemotherapy between October and January 1996-1997. Two weeks after the last chemotherapy, his leukemia relapsed. He went for another protocol in which he received lymphocyte infusion (helper – T cells) followed by three weeks of interleuken 2. injections. In spite of all these, his blast continued to increase and the haematocrit kept going down. He was transfused with two pints of whole blood every other day. He also received multiple platelet transfusions. He case was dismissed by his doctors at Dana Farber Cancer Centre (one of the best two cancer centers in the world) as irredeemable. He was already discharged and given two to three days at most to die because his body rejected all the blood transfused. Jobelyn helped to prolong his life for more than he was expected to live. Though the patient is now deceased, his condition while on this therapy could best be summarized in the spouse’s own words. “The Jobelyn definitely stabilized his hematocrit for as long as he took it and it may have prolonged his life a few weeks. Having been able to keep him alive for a month after they thought he was going to die, was worth it”